Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Phase 2 safety and antiviral activity of SAB-185, a novel polyclonal antibody therapy for non-hospitalized adults with COVID-19.

Babafemi O Taiwo,Kara W Chew,Carlee Moser,David Alain Wohl,Eric S Daar,Jonathan Z Li,Alexander L Greninger,Christoph Bausch,Thomas Luke,Keila Hoover,Gene Neytman,Mark J Giganti,Maxine Olefsky,Arzhang Cyrus Javan,Courtney V Fletcher,Joseph J Eron,Judith S Currier,Michael D Hughes,Davey M Smith

The Journal of infectious diseases（2023）

Cited 1|Views12
No score
Abstract
SAB-185 was safe and generally well tolerated and demonstrated modest antiviral activity in predominantly low-risk non-hospitalized adults with COVID-19.
More
Translated text
Key words
COVID-19,SAB-185,antibody,polyclonal,transchromosomic,treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined